Having problems with message search?
excerpt:
Members of the Committee on Safety of Medicines will, for the first time, be scrutinised over the drugs companies they are supposed to be monitoring.
By the time medicines reach patients they have been through, it is hoped, a thorough testing and licensing system.
But for a long time there have been concerns about the links between the people who do the licensing and the pharmaceutical industry.
Now Channel Four News has learned that health ministers are for the first time to demand greater transparency.
By the time medicines reach patients they have been through, it is hoped, a thorough testing and licensing system.
But for a long time there have been concerns about the links between the people who do the licensing and the pharmaceutical industry.
Now Channel Four News has learned that health ministers are for the first time to demand greater transparency.
The Committee on Safety of Medicines advises the Medicines and Healthcare Products Regulatory Agency - the MHRA - and they issue licenses for all drugs.
From now on, Channel 4 News has been told, all members - from the chairman to lay experts - will no longer be able to hold any personal interest in the pharmaceutical industry.
From now on, Channel 4 News has been told, all members - from the chairman to lay experts - will no longer be able to hold any personal interest in the pharmaceutical industry.
Offline 
Send Email